Cart
sales@molnova.com
Fosravuconazole L-lysine ethanolate
CAS No. 914361-45-8
Fosravuconazole L-lysine ethanolate ( BMS-379224 L-lysine ethanolate; E-1224 L-lysine ethanolate )
Catalog No. M24954 CAS No. 914361-45-8
FosravuconazoleL-lysine ethanolate is a broad-spectrum antifungal agent. In Japan, it is approved for the treatment of onychomycosis, a fungal infection of the nail. It is a prodrug that is converted into ravuconazole.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 48 | In Stock |
|
| 5MG | 68 | In Stock |
|
| 10MG | 110 | In Stock |
|
| 25MG | 215 | In Stock |
|
| 50MG | 340 | In Stock |
|
| 100MG | 560 | In Stock |
|
| 200MG | 791 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFosravuconazole L-lysine ethanolate
-
NoteResearch use only, not for human use.
-
Brief DescriptionFosravuconazoleL-lysine ethanolate is a broad-spectrum antifungal agent. In Japan, it is approved for the treatment of onychomycosis, a fungal infection of the nail. It is a prodrug that is converted into ravuconazole.
-
DescriptionFosravuconazoleL-lysine ethanolate is a broad-spectrum antifungal agent. In Japan, it is approved for the treatment of onychomycosis, a fungal infection of the nail. It is a prodrug that is converted into ravuconazole.
-
SynonymsBMS-379224 L-lysine ethanolate; E-1224 L-lysine ethanolate
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number914361-45-8
-
Formula Weight739.7
-
Molecular FormulaC31H40F2N7O8PS
-
Purity>98% (HPLC)
-
SolubilityDMSO:48mg/mL (64.89mM)
-
SMILESN#CC1=CC=C(C2=CSC([C@H](C)[C@@](OCOP(O)(O)=O)(C3=CC=C(F)C=C3F)CN4N=CN=C4)=N2)C=C1.CCO.N[C@H](C(O)=O)CCCCN
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Diniz LF, Mazzeti AL, Caldas IS, Ribeiro I, Bahia MT. Outcome of E1224-Benznidazole Combination Treatment for Infection with a Multidrug-Resistant Trypanosoma cruzi Strain in Mice. Antimicrob Agents Chemother. 2018;62(6):e00401-18. Published 2018 May 25. doi:10.1128/AAC.00401-18Watanabe S, Tsubouchi I, Okubo A. Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study. J Dermatol. 2018;45(10):1151-1159. doi:10.1111/1346-8138.14607
molnova catalog
related products
-
IM176OUT05
IM176OUT05 activates stem cell metabolism with hair regrowth-promoting effects.
-
Cephapirin Benzathin...
Cephapirin Benzathine is a semisynthetic broad-spectrum first-generation cephalosporin with antibacterial activity.
-
Eupalinolide H
Eupalinolide H, a sesquiterpene lactone, has the potential to be used as natural anti-inflammatory agent.
